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Abstract
Dosage compensation ensures similar levels of X-linked gene products in males (XY or XO) and females (XX), despite their
different numbers of X chromosomes. In mammals, flies, and worms, dosage compensation is mediated by a specialized
machinery that localizes to one or both of the X chromosomes in one sex resulting in a change in gene expression from the
affected X chromosome(s). In mammals and flies, dosage compensation is associated with specific histone posttranslational
modifications and replacement with variant histones. Until now, no specific histone modifications or histone variants have
been implicated in Caenorhabditis elegans dosage compensation. Taking a candidate approach, we have looked at specific
histone modifications and variants on the C. elegans dosage compensated X chromosomes. Using RNAi-based assays, we
show that reducing levels of the histone H2A variant, H2A.Z (HTZ-1 in C. elegans), leads to partial disruption of dosage
compensation. By immunofluorescence, we have observed that HTZ-1 is under-represented on the dosage compensated X
chromosomes, but not on the non-dosage compensated male X chromosome. We find that reduction of HTZ-1 levels by
RNA interference (RNAi) and mutation results in only a very modest change in dosage compensation complex protein levels.
However, in these animals, the X chromosome–specific localization of the complex is partially disrupted, with some nuclei
displaying DCC localization beyond the X chromosome territory. We propose a model in which HTZ-1, directly or indirectly,
serves to restrict the dosage compensation complex to the X chromosome by acting as or regulating the activity of an
autosomal repellant.
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Introduction
Many species- such as humans, mice, flies, and worms- utilize a
chromosome-based mechanism to establish sex. This results in a
difference in sex chromosome number between the sexes that, left
uncorrected, puts one sex at a great selective disadvantage. In
order to combat this, these organisms employ a second mechanism
to ensure that the same amount of sex chromosome-linked gene
expression occurs in both sexes. This mechanism is called dosage
compensation [1–4].
In flies and mammals, specific posttranslational histone
modifications and/or replacement of core histones with variants
are key features of the dosage compensated X chromosomes [5].
Dosage compensation in flies is brought about by the MSL (male-
specific-lethal) complex that localizes to the single X chromosome
in males resulting in a two-fold increase in gene expression [6,7].
The MSL complex is made up of at least five proteins (MSL1 [8],
MSL2 [9], MSL3 [10], MLE [11], and MOF [12]), and one of two
non-coding RNAs (roX 1 and roX2, RNA on the X [13,14]). The
hypertranscribed male X is enriched for histone H4 lysine 16
acetylation (H4K16ac) [15]. MOF (males-absent on the first) places
the H4K16ac mark on the male X and this function is essential for
dosage compensation [16–18]. In mammals, one of the two female
X chromosomes is transcriptionally inactivated [3]. The inactive X
is targeted for silencing by the non-coding RNA, Xist in mice
[19,20], XIST in humans [21], that coats the inactive X
chromosome [22]. This is followed by chromosome-wide histone
H3 lysine 27 tri-methylation (H3K27me3) by Polycomb repressor
complex 2 (PRC2) [23], and histone H2A and H2A.Z mono-
ubiquitylation by Polycomb repressor complex 1 (PRC1) [24,25].
On the inactive X chromosome, there is also an enrichment of
histone H3 lysine 9 dimethylation (H3K9me2) [26] and an
enrichment of the histone variant macroH2A [27]. However,
other modifications and variants are specifically under-represented
on the inactive X: di-, and trimethylation of histone H3 lysine 4
(H3K4me) [26,28], dimethylation of histone H3 arginine 17
(H3R17me2) and H3 lysine 36 (H3K36me2) [29], acetylation of
the N-terminal tails of histones H2A, H3 and H4 [30–32], and the
phosphorylated form of macroH2A1 [33]. These and other
modifications are thought to be vital for the resulting essential
change in X-linked gene expression in male flies and female
mammals.
In C. elegans, dosage compensation is achieved by the dosage
compensation complex (DCC), which binds both X chromosomes
in hermaphrodites to downregulate gene expression two-fold [2].
DPY-27 [34], MIX-1 [35], DPY-26 [36], DPY-28 [37], and
CAPG-1 [38] form a condensin-like complex, condensin I
DC.
SDC-2 [39], SDC-3 [40], and DPY-30 [41] are thought to be
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as DPY-21 [39] and SDC-1 [42,43], to the X chromosomes in
hermaphrodites. All DCC proteins, except for SDC-2, are
supplied maternally to the oocyte, and are initially present in
both male and hermaphrodite embryos [2]. SDC-2 is not
contributed maternally, expressed only in hermaphrodites and is
thought to confer both sex-specificity and X-chromosome
specificity to dosage compensation [39]. The DCC initially binds
to rex (recruitment elements on the X) sites, which represent sites of
DCC enrichment on the X chromosome, and spreads in cis along
the lengths of both X chromosomes in the hermaphrodite [44–47].
As a result, gene expression from the two hermaphrodite X
chromosomes is down-regulated by half, thus limiting X-linked
gene products to levels produced in XO males [48]. Condensin
complexes are well known for their roles in affecting chromosome
architecture during mitosis and meiosis [49], so it is believed that
the DCC may be altering the overall organization of the X
chromosomes to dampen gene expression during interphase. A
chromosome-wide architectural change by the DCC condensin
may require or lead to specific modifications to the basic
organizational unit of chromatin, the nucleosome. However, no
nucleosomal changes, such as posttranslational modification of
histones or histone variants, have been previously implicated to
play a role in C. elegans dosage compensation.
While in somatic cells of hermaphrodites the X chromosome is
subject to dosage compensation, in the postembryonic germ line of
both sexes the X is subject to a distinct form of chromosome-wide
regulatory process: global repression throughout meiosis in males
and during early meiosis in hermaphrodites [50]. The maternal
effect sterility (MES) proteins mediate silencing of the germ line X
chromosome and their function is required for germ line viability
[50–52]. Three of the mes genes (mes-2, mes-3, and mes-6) encode
proteins that function together in a PRC2-like complex, which
localizes to the germ line X-chromosome(s) and leads to
enrichment of H3 lysine 27 trimethylation on the X [53–56]. By
contrast, an additional MES protein, MES-4, localizes only to the
autosomes and not X, and its function is necessary for germ line X
silencing [51,57]. Additionally, the silenced germ line X
chromosomes show a significant depletion of activating marks
such as acetylation of the N terminal tail of histone H4 and
methylation of lysine 4 on H3 [50,58].
From studies of dosage compensation in other organisms and of
germ line X chromosome silencing in C. elegans, there are many
well-documented links between different forms of chromosome-
wide gene regulation and specific nucleosome characteristics. This
led us to explore whether we might find a similar link between C.
elegans dosage compensation and nucleosome composition. We
were interested to see if any histone modifications or histone
variants play a functional role in dosage compensation in worms.
In this paper we report on the role of the C. elegans histone H2A.Z
variant (HTZ-1).
The histone variant H2A.Z is conserved from yeast to humans
and has been implicated in diverse biological processes. Interest-
ingly, depending on its histone partner in the nucleosome core
particle, H2A.Z can either stabilize or destabilize the nucleosome
[59]. When partnered with histone H3, the H2A.Z-containing
nucleosome becomes more stable, but when partnered with the
histone variant H3.3, the nucleosome becomes destabilized.
Unstable H2A.Z/H3.3. nucleosomes may function to poise genes
for activation. Consistently, studies in several organisms implicate
H2A.Z in various aspects of transcription activation. In Tetrahy-
mena, hv1/H2A.Z associates with the transcriptionally active
macronucleus [60–62]. Genome-wide localization studies in yeast
[63–66], worms [67], flies [68], plants [69], and humans [70],
revealed that H2A.Z preferentially localizes to 59 ends of genes,
consistent with a role in transcription activation. Loss of Htz1 has
been shown to diminish RNA Pol II binding to promoters, slow
the activation of regulated genes, or prevent rapid reactivation of
recently repressed genes [66,71,72]. A role of HTZ-1 to poise
genes for rapid activation has also been observed in a study of the
C. elegans H2A.Z homolog, HTZ-1 [73].
However, H2A.Z also localizes to regulatory regions not
corresponding to promoters to exert other functions. In budding
yeast, Htz1 also functions at boundary elements to protect genes
from heterochromatinization by antagonizing the spread of
silencing complexes [74]. This antisilencing functions at the global
level, not just locally [75]. Consistent with an antisilencing role, in
plants, H2A.Z antagonizes DNA methylation [69]. H2A.Z also
localizes to insulator elements in chicken [76], and to functional
regulatory elements in human cells [70]. It has been proposed that
in this context, the presence of an H2A.Z/H3.3 labile nucleosome
prevents the spreading of heterochromatic marks [59].
On the other hand, H2A.Z also plays a role in heterochromatin
formation. In this context, H2A.Z most likely partners with H3 to
form stable nucleosomes [59]. In mammals and in flies, H2A.Z
associates with pericentric heterochromatin and interacts with
heterochromatin protein HP1 [77–80]. Mammalian H2A.Z also
becomes incorporated into the inactive XY body following meiosis
[81]. However, H2A.Z is significantly underrepresented and
differentially modified on the mammalian inactive X chromosome
in somatic cells, indicating that H2A.Z enrichment is not a general
feature of all heterochromatin [25,79,82]. Consistent with that,
H2A.Z is not enriched at heterochromatic chromocenters in plants
[69,83].
Here we show that in C. elegans the histone variant H2A.Z/
HTZ-1 functions in dosage compensation. Consistent with
previous reports [67], we find that HTZ-1 is under-represented
on the dosage compensated X chromosomes in somatic nuclei of
hermaphrodites. However, we do not observe HTZ-1 depletion on
the non-dosage compensated X chromosome in male somatic
nuclei. We also see an underrepresentation of HTZ-1 on the silent
Author Summary
In organisms where females have two X chromosomes and
males only have one, a mechanism called dosage
compensation ensures that both sexes receive the same
amount of information from their X chromosomes.
Disruption of dosage compensation leads to lethality in
the affected sex. While the precise mechanisms of dosage
compensation differ between organisms, changes to the
structure of the X chromosomes are involved in each case.
The DNA of all chromosomes is packaged into a complex
protein–DNA structure called chromatin. The most basic
level of packaging involves wrapping DNA around a group
of small proteins called histones. In both mammals and
flies, dosage compensation is associated with specific
changes to the histones on the dosage compensated X
chromosome. Until now, no such change has been
associated with dosage compensation in worms. Here we
present evidence that the histone variant HTZ-1/H2A.Z
plays a role in dosage compensation in the worm.
Specifically, we suggest that HTZ-1 functions to ensure
that only the X chromosomes, and not the other
chromosomes, are subjected to dosage compensation.
This suggests that, despite different mechanisms, one
common theme of dosage compensation is a change at
the level of the histones associated with the chromosomal
DNA.
HTZ-1 Restricts DCC to X
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Partial depletion of HTZ-1 does not lead to an overall decrease in
DCC protein levels. Instead we see mislocalization of the DCC
away from the X chromosomes and onto autosomes. These results
reveal an HTZ-1-dependent activity that serves to repel the DCC
away from autosomes. We propose that HTZ-1 plays a role in
dosage compensation by directly or indirectly restricting binding of
the DCC to the X chromosomes.
Results
HTZ-1 function promotes dosage compensation
To search for chromatin modifiers involved in worm dosage
compensation, we utilized two RNAi-based assays in a genetic
background sensitized for detecting disturbances in dosage
compensation. We tested genes encoding C. elegans homologs of
histone variants, genes implicated in modifying chromatin via
posttranslational histone modifications (such as acetylation or
methylation) or chromatin remodeling [84], as well as genes
annotated to contain chromo-, bromo- or SET domains
(Wormbase [http://www.wormbase.org], release WS201).
The first assay was completed in the sex-1(y263) mutant
background. sex-1 functions genetically as an X signal element
by repressing xol-1, the master switch regulating both sex-
determination and dosage compensation [85,86]. In addition,
sex-1 plays a role downstream of xol-1, promoting dosage
compensation in hermaphrodites [87]. In sex-1(y263) mutant
hermaphrodites, dosage compensation is partially impaired,
resulting in 15–30% embryonic lethality. In these worms, partial
loss-of-function due to feeding RNAi of a gene important for
dosage compensation leads to increased lethality [87]. A second
genetic assay was based on the rescue of males that inappropriately
turn on dosage compensation due to a xol-1(y9) mutation.
Expression of xol-1 in males is essential to prevent dosage
compensation of the single X chromosome [88]. Mutations in
xol-1 are male lethal due to ectopic dosage compensation, leading
to abnormally low levels of X-linked gene expression. The sex-
1(y263) mutation partially weakens dosage compensation, as
described above. xol-1(y9) sex-1(y263) males die, but they can be
rescued by feeding RNAi of dosage compensation genes [38,87].
To ensure a consistent proportion of males in our test strain, we
perform these assays in a strain that also carries the him-8(e1489)
allele. Mutations in him-8 cause X chromosome nondisjunction in
meiosis and results in a predictable 38% of XO progeny each
generation [89].
RNAi of DCC components show near complete sex-1 lethality
and results in 33–60% rescue of him-8(e1489); xol-1(y9) sex-1(y263)
males in these two assays [38]. One candidate, the histone variant
htz-1 (C. elegans H2A.Z homolog) showed a similar genetic
interaction. RNAi in the wild type background leads to little to
no lethality, while htz-1 RNAi in the sex-1(y263) background leads
to near complete embryonic lethality (Figure 1A). In the him-
8(e1489); xol-1(y9) sex-1(y263) background, RNAi of the histone
variant htz-1 resulted in over 15% rescue (Figure 1B). To ensure
that these phenotypes are not caused by general disruption to
chromatin, we also tested two genes encoding H3.3 histone
variants (his-71 and his-72) [90], and genes encoding linker
histones [his-24 (H1.1), hil-3 (H1.3), hil-4 (H1.4), hil-5 (H1.5), hil-6
(H1.6), and hil-7 (H1.Q)] [91]. RNAi of these genes did not show
similar genetic interactions. RNAi of many other chromatin
factors also failed to result in significant male rescue (for a
complete list, see Table S1). The chromatin remodeling enzyme
isw-1, and the histone deacetylase let-418 are shown as examples
(Figure 1B). We conclude that depletion of HTZ-1 leads to
disruption of dosage compensation.
HTZ-1 is underrepresented on hermaphrodite X
chromosomes but not the male X chromosome
A previous study found that in worms HTZ-1 preferentially
localizes to promoters, as in other organisms [67]. Furthermore,
fewer peaks of HTZ-1 incorporation were found on the X
chromosome, as compared to autosomes. The authors attribute
this difference to the relative lack of developmentally important
genes on the X chromosome, rather than a direct role in dosage
compensation [67]. Our RNAi data above indicates that HTZ-1
function is needed for wild type levels of dosage compensation, but
does not address whether this role is direct or indirect. That is, htz-1
Figure 1. HTZ-1 function is needed for dosage compensation.
(A) Embryonic lethality caused by feeding RNAi in wild type (N2) and
sex-1(y263) X hermaphrodite worms. RNAi of both dpy-27 (nN2=1173;
nsex-1=566) and htz-1 (nN2=1292; nsex-1=385) leads to synergistic
embryonic lethality in the sex-1 mutant background that is significantly
different from levels observed after vector RNAi (nN2=459; nsex-1=504)
(p=1.84610
25, and p=4.9610
25 respectively). RNAi of his-71 (39-UTR,
nN2=1901 ;nsex-1=1037), his-72 (39-UTR, nN2=2821; nsex-1=1381), his-24
(nN2=438; nsex-1=933), hil-3 (nN2=378; nsex-1=682), hil-4 (nN2=412;
nsex-1=853), hil-5 (nN2=440; nsex-1=1083), hil-6 (nN2=350; nsex-1=481 ),
or hil-7 (nN2=413; nsex-1=882) does not significantly affect sex-1
embryonic lethality compared to vector. (B) Male survival caused by
feeding RNAi in him-8(e1489) IV; xol-1(y9) sex-1(y263) X worms. Both
capg-1 (n=771) and htz-1 (n=1337) RNAi rescue a significant
proportion of males (p=5. 2610
26 and p=3.8610
24 respectively)
compared to vector (n=1245). RNAi of his-71 (coding region, n=623),
his-71 (39-UTR, n=1786), his-72 (39-UTR, n=639), his-24 (n=633), hil-3
(n=810), hil-4 (n=1332), hil-5 (n=1847), hil-6 (n=1139), and hil-7
(n=868), isw-1(n=1004), or let-418 (n=1313) does not lead to
significant male rescue. Error bars indicate standard deviation for four
experiments. Asterisks indicate a p value of less than 0.05 by student’s
T-test analysis comparing vector and experimental RNAi data.
doi:10.1371/journal.pgen.1000699.g001
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indirectly affect dosage compensation by regulating expression of
known or unknown dosage compensation genes. To begin to
distinguish between these possibilities, we analyzed the distribution
of HTZ-1 in male and hermaphrodite nuclei. We reasoned that if
HTZ-1 functions in dosage compensation, its distribution in the
nucleus may be different in males (dosage compensation inactive)
and hermaphrodites (dosage compensation active).
To analyze HTZ-1 distribution, we took advantage of a strain
expressing a YFP-HTZ-1 fusion protein, or used an HTZ-1
specific antibody. The specificity of our HTZ-1 antibody is
demonstrated by recognition of a protein of the predicted size on
western blots and reduction of signal after HTZ-1 depletion on
both western blots and by immunofluorescence (IF) (Figure S1).
We marked the X-chromosome territory with an antibody specific
to DPY-27 (marks the X chromosomes in hermaphrodites only) or
X-paint fluorescent in situ hybridization (FISH) (to mark the X
chromosomes in both sexes). Consistent with a previous report
[67], we observed reduced HTZ-1 staining on the dosage
compensated X chromosomes in mid-to-late stage hermaphrodite
embryos after the onset of dosage compensation by DPY-27/
HTZ-1 IF (Figure 2A and 2B), and combined X-Paint FISH/
HTZ-1 IF (Figure 2C). We also observed reduced levels of YFP-
HTZ-1 in the territory of the X-chromosomes in transgenic
hermaphrodite embryos (Figure S2). However, in males we did not
observe a decrease in HTZ-1 staining intensity in the X
chromosome territory of somatic nuclei (Figure 2C). These results
indicate that reduced HTZ-1 levels are specific to dosage
compensated X chromosomes and not a general feature of X
chromosomes in both sexes in adult animals.
HTZ-1 depletion does not lead to a decrease in DCC
protein levels
The results of the genetic assays and localization assays
appeared contradictory: reduced htz-1 expression disrupts dosage
compensation, yet the protein itself is depleted on the dosage
compensated X chromosomes. Therefore, we wanted to explore
how dosage compensation is affected in htz-1 depleted animals. If
HTZ-1 functions in dosage compensation indirectly (by regulating
expression of dosage compensation genes) we would predict to see
a decrease in DCC protein levels upon HTZ-1 depletion. We
analyzed worms carrying the htz-1 deletion allele tm2469 that
removes 345 of 885 base pairs from htz-1 and likely represents a
null allele. htz-1(tm2469) homozygous progeny of heterozygous
mothers (m
+z
2) develop into healthy adults but are sterile, as
reported [67]. However, the tm2469 deletion appears to affect
expression of not just htz-1, but the neighboring gene as well
(Figure S3). It was therefore important to obtain HTZ-1-depleted
worms using an alternate method and to confirm that phenotypes
are due to HTZ-1 depletion, and not depletion of the neighboring
gene product. As an alternative method, we depleted HTZ-1 levels
by feeding worms bacteria expressing double stranded RNA
corresponding to htz-1. As a control, worms were fed bacteria
carrying an empty vector. Feeding RNAi in wild type animals
greatly reduced HTZ-1 as detected both by immunofluorescence
and quantitative Western blot analyses (89% reduction) (Figure 3B
and Figure S1).
To investigate the possibility that HTZ-1 depletion leads to a
decrease in DCC protein levels, we quantified protein levels by
western blotting of HTZ-1 depleted and control animals. Although
HTZ-1 levels were clearly reduced after htz-1 RNAi, we did not
observe a dramatic change in DCC protein levels (Figure 3A and
3C). Levels of DPY-27 and CAPG-1 show a very slight decrease
while MIX-1, DPY-26, and DPY-28 show very slight increases
after htz-1 RNAi. Our results suggest that, HTZ-1 reduction does
not lead to a significant defect in overall DCC protein levels.
However, we cannot exclude the possibility that the timing of
DCC gene expression is changed (delayed) in HTZ-1 depleted
cells, as was observed for genes involved in foregut development
[73]. It is also possible that a small amount HTZ-1 that remains
after feeding RNAi is sufficient for DCC gene expression, but
more complete HTZ-1 depletion would result in a significant
decrease in DCC protein levels.
SDC-2, the primary determinant of hermaphrodite fate, is the
only DCC protein whose expression in the zygote is essential [39].
The remaining DCC proteins are maternally loaded into the
oocyte and this maternal load is sufficient to carry out dosage
compensation in the developing embryo. Therefore, it was
important to determine whether sdc-2 transcript levels are affected
after HTZ-1 depletion. We analyzed sdc-2 mRNA levels in HTZ-1
depleted and control animals by reverse transcription followed by
quantitative polymerase chain reaction (RT-qPCR) and observed
no significant change in sdc-2 expression (Figure 3D). We conclude
that the changes observed in DCC protein and RNA levels are not
likely to be sufficient to explain the observed requirement for
HTZ-1 to maintain wild type levels of dosage compensation.
DCC localization is disrupted in HTZ-1-depleted animals
An alternative possibility is that HTZ-1 has a more direct role in
dosage compensation by affecting DCC localization or function.
To explore this possibility, we used immunofluorescence to
observe DCC localization in HTZ-1-depleted worms. The DCC
was clearly present in nuclei of htz-1(RNAi) animals, again
suggesting that HTZ-1 depletion does not lead to a significant
reduction in DCC protein levels. However, the territory occupied
Figure 2. HTZ-1 depletion on dosage compensated X chromo-
somes. HTZ-1 and DPY-27 localization by IF in hermaphrodite adult
somatic nucleus (A) and embryonic nucleus after the onset of dosage
compensation (B). HTZ-1 (green) staining is reduced in the region
containing the X chromosomes, as marked by DPY-27 (red) staining. (C)
HTZ-1 localization by IF (green) and X-Chromosome labeling by FISH
(red) in adult hermaphrodite (top) and male (bottom) somatic nuclei.
HTZ-1 staining is reduced on the hermaphrodite X chromosomes but
not on the male X chromosome.
doi:10.1371/journal.pgen.1000699.g002
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appearance than in wild type nuclei (Figure 4).
We hypothesized that the diffuse appearance of the DCC
reflected mislocalization of the DCC away from the X
chromosome. To observe DCC localization relative to X
chromosomes, we combined DCC immunofluorescence with X-
paint FISH in htz-1(RNAi) (Figure 4) and mutant (Figure 5)
animals. We used intestinal nuclei because they are 32-ploid,
allowing for easier visualization of sub-nuclear regions by FISH
[92]. To determine the degree of colocalization between X-Paint
and DPY-27 signals we determined Pearson’s correlation coeffi-
cient (Rr) values (see Materials and Methods). An Rr value of +1
indicates a complete and positive correlation between two signals
within a region of interest while a value of 0 indicates no linear
relationship between the two signals.
In vector control RNAi animals we observed that the DCC was
highly restricted to the X chromosomes and the mean Rr was
0.6560.14. Rr was greater than 0.5 in the vast majority of nuclei
observed (88%), and only a minority of nuclei had Rr values
between 0.5 and 0.2 (,12%). No correlation values of less than 0.2
were observed in these animals. Representative nuclei and
corresponding Rr are shown in Figure 4A. By contrast, after htz-1
RNAi, the mean Rr for htz-1 RNAi nuclei was 0.4460.20,
significantly lower than control (p=5.79E-8). The majority of
nuclei (58%) had DPY-27/X-paint correlation values below 0.5,
and27%ofnucleihadvaluesbelow thelowestvalueobservedinthe
control. Representative htz-1(RNAi) nuclei and corresponding Rr
values are shown in Figure 4B. A summary of DPY-27/X-Paint
colocalization quantification after vector and htz-1 RNAi is shown
in Figure 4C.
DCC mislocalization was also observed in intestinal nuclei of
homozygous htz-1(tm2469) hermaphrodite progeny of heterozygous
mothers (m+z2) (Figure 5) and in HTZ-1-depleted embryos (Figure
S4). The mislocalization phenotype observed in htz-1(tm2469)
(Figure 5) mutant animals was very similar to the observations made
after htz-1 RNAi. In wild-type hermaphrodites only 5% of nuclei
observed had Rr values below 0.5, but a majority of htz-1(tm2469)
nuclei (59%) had values below 0.5. Additionally, 45% of nuclei
Figure 4. HTZ-1 depletion disrupts DCC restriction to the X
chromosomes. Adult hermaphrodite intestinal nuclei were stained
with a-DPY-27 (green), X-paint FISH probe (red) and DAPI (gray). (A)
Representative nuclei observed after vector RNAi treatment. (B)
Representative nuclei observed after htz-1 RNAi treatment. (C) Summary
of quantification of DPY-27 colocalization with the X chromosomes
following vector and htz-1 RNAi treatment. After vector RNAi, the
average Rr value from three independent experiments was 0.6560.14
(n=41). After htz-1 RNAi, the average value from three independent
experiments was reduced to 0.4460.2 (n=48).
doi:10.1371/journal.pgen.1000699.g004
Figure 3. htz-1 RNAi does not significantly decrease DCC levels.
HTZ-1 levels were reduced by feeding RNAi in wild type worms. (A,B) An
equal number of control vector and htz-1 RNAi adult animals were
collected for quantitative western blot analysis to observe levels of HTZ-
1, MIX-1, DPY-27, DPY-26, CAPG-1, DPY-28 and a-Tubulin (loading
control) after RNAi treatment. Band intensities were quantified and
normalized to tubulin (C). RNAi significantly reduces HTZ-1 levels, but
no significant decrease was seen in levels of DCC subunits. Vector and
htz-1 RNAi adults were also collected for RT-qPCR analysis (D). htz-1
expression is significantly reduced in htz-1 animals (p=3.1610
26), but
there is no significant difference in sdc-2 expression between vector and
htz-1 RNAi animals.
doi:10.1371/journal.pgen.1000699.g003
HTZ-1 Restricts DCC to X
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nuclei (Figure 5B and 5C). We also analyzed HTZ-1-depleted
embryos after the 50-cell stage in development (after the onset of
dosage compensation). We observed 16% of htz-1-depleted embryos
with a diffuse nuclear DCC localization pattern (as opposed to 2%
of vector RNAi control embryos), confirming that DCC misloca-
lization is not tissue specific (Figure S4).
Finally, we analyzed DCC distribution in nuclei of ssl-1 (n4077)
mutant animals. ssl-1 encodes a homolog of Swr1, the catalytic
subunit of Swr1-com, the complex responsible for exchanging
H2A for H2A.Z [93–96]. Consistent with this function, ssl-
1(n4077) m+z2 homozygous animals have reduced HTZ-1
staining (Figure 5A). In ssl-1(n4077) hermaphrodites, 43% of
nuclei observed had Rr values below 0.5, similar to what we
observe after htz-1 RNAi and in htz-1(tm2469) animals. Also, 33%
of ssl-1 nuclei had Rr values below the lowest value observed in
wild type nuclei, confirming that reduced HTZ-1 disrupts the
localization of DCC to the X chromosomes (Figure 5B and 5C).
Together, these results strongly suggest that HTZ-1, a protein
more abundant on autosomes, is important for restricting
localization of the DCC to the X chromosomes.
DCC localization to autosomes upon HTZ-1 depletion
The portion of DCC which is not associated with the X
chromosome appears nonetheless bound to chromatin. When we
combined X-Paint FISH/DPY-27 IF with a protocol previously
shown to extract nucleoplasmic proteins [97], we were unable to
remove the non-X associated DCC within intestinal nuclei of htz-1
RNAi animals (Figure 6A). This suggests that the non-X associated
DCC is associated with autosomal chromatin.
To confirm DCC association with autosomes, we analyzed
prophase chromosomes in both vector control and htz-1 depleted
embryos. We reasoned that individualized mitotic chromosomes
would allow for more conspicuous visualization of DCC
localization. To mark mitotic nuclei, embryos were co-stained
with a-Phospho-Histone H3 Serine 10. In control embryos, DCC
localization was largely restricted to two chromosomes in prophase
nuclei. After htz-1 RNAi, however, 32% of prophase nuclei had
low-level DCC staining on more than two chromosomes
(Figure 6B). These data indicate that the DCC associates not
only with the X chromosome, but also with autosomes in HTZ-1-
depleted animals. Taken together, these results suggest the
existence of an HTZ-1 dependent autosomal repellent activity.
In wild type animals, this activity restricts localization of the DCC
to the X chromosome. Loss of htz-1 reduces the efficiency of this
repellant, allowing the DCC to bind other chromosomes.
HTZ-1 levels are also reduced on the X chromosomes in
the male and hermaphrodite germ lines
In different organisms, H2A.Z has been observed to be either
enriched in silent chromatin, (such as mammalian and Drosophila
centromeres [77–80], or the XY sex body in the mammalian germ
line [81]) or depleted in silent chromatin (such as heterochromatic
chromocenters in plants [69,83], or the transcriptionally inactive
micronucleus in Tetrahymena [60–62]). Dosage compensation in
worms is thought to involve two-fold downregulation of gene
expression, but not complete silencing [2]. To explore whether
HTZ-1 localizes to silent chromatin in worms, we examined its
distribution in the germ line, where the X chromosomes are
subject to chromosome-wide silencing by a mechanism unrelated
to dosage compensation [50]. In the male germ line, the single X
chromosome is subject to meiotic silencing of unpaired chromatin
and is silent throughout meiosis. In the hermaphrodite germ line,
the paired X chromosomes are silent during early meiosis, but
become transcriptionally active in later stages [50]. To test HTZ-1
levels on the silent X chromosome in the germ line, we performed
immunofluorescence experiments on dissected male and her-
maphrodite gonads. To distinguish the X from autosomes we used
antibodies specific to MES-4, H3K27me3, or H4K16ac, all of
which have been used in previous studies to distinguish the X from
autosomes in the germ line. MES-4, a SET-Domain protein, is
enriched on autosomes and markedly depleted from the X
chromosome in the germ line [51,57]. Conversely, H3K27me3 is
enriched on the silent X chromosomes in the germ line [53]. In the
male germ line, H4K16ac is present on autosomes but absent from
the unpaired X chromosome [50]. We found that HTZ-1 levels
Figure 5. DCC mislocalization in htz-1(tm2469) and ssl-1(n4077)
adult hermaphrodites. (A) HTZ-1 (red) and DAPI (blue) staining in
wild-type, htz-1(tm2469) m+z2 and ssl-1(n4077) m+z2 adult hermaph-
rodite intestinal nuclei. HTZ-1 levels are reduced in htz-1(tm2469)m+z2
and ssl-1(n4077) m+z2 adult hermaphrodites. (B) Representative wild
type (Rr=0.67), htz-1(tm2469)m+z2 (Rr=0.18) and ssl-1(n4077) m+z2
(Rr=0.33) adult hermaphrodite intestinal nuclei stained with a-DPY-27
(green), X-paint FISH probe (red) and DAPI (grayscale). (C) Summary of
quantification of DPY-27 colocalization with the X chromosomes
observed in wild type (mean Rr=0.70, n=22), htz-1(tm2469)m+z2
(mean Rr=0.45, n=22) and ssl-1(n4077) m+z2 (mean Rr=0.54, n=21)
adult hermaphrodite intestinal nuclei.
doi:10.1371/journal.pgen.1000699.g005
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male and hermaphrodite germ lines (Figure 7). Thus, underrep-
resentation of HTZ-1 appears to be a general feature of both types
of chromosome-wide repression in the worm: two-fold downreg-
ulation by dosage compensation and complete meiotic silencing.
The possible involvement of HTZ-1 in germ line X chromosome
silencing will be explored elsewhere.
Discussion
Dosage compensation in C. elegans is accomplished by the DCC,
a complex of proteins that binds the two X chromosomes in
hermaphrodites to down-regulate expression of genes two-fold. In
this study we report on the role of the histone variant H2A.Z/
HTZ-1 in this process. HTZ-1 is less abundant on the dosage
compensated X chromosomes in hermaphrodites but is found at
higher levels on autosomes and X chromosomes in male somatic
cells. When htz-1 expression is reduced, levels of DCC proteins do
not change. However, binding of the DCC is no longer restricted
to the X chromosomes and dosage compensation is impaired.
Models for HTZ-1 function in dosage compensation
One of the intriguing challenges in the study of dosage
compensation is to understand how the DCC machinery is able
to specifically target the X chromosomes for regulation. Our
studies indicate that when HTZ-1 is depleted, the DCC appears to
be no longer targeted correctly to the X chromosome. Rather than
binding solely to the X chromosomes, the complex now binds
autosomes as well. These results reveal that the normal function of
HTZ-1 (or an HTZ-1 regulated factor) includes keeping the DCC
away from autosomes. Previous studies indicated that specific
DCC binding sites on the X chromosome, so-called rex sites
(recruiting element on X), are important for attracting the DCC to
the X chromosome ([44–47]). Taken together, these data suggest
that positive forces (X-specific recruitment elements that attract
the DCC) and negative forces (autosomal chromatin that repels
the DCC) cooperate to discriminate the X from autosomes
(Figure 8).
The mechanism of how HTZ-1 restricts DCC localization is
unclear. We will consider three possible models. First, HTZ-1 may
serve as a direct regulator of DCC binding. Targeting of the DCC
to the X chromosome is believed to be a two-step process. The
complex initially binds to an estimated 200 rex sites, followed by
dispersal to numerous so-called dox sites (dependent on X) or ‘‘way
Figure 6. DCC associates with autosomes in HTZ-1-depleted
cells. (A) DPY-27 (green) and X-chromosome (red) localization in vector
and htz-1 RNAi treated hermaphrodite adult intestinal nuclei after
detergent extraction of nucleoplasmic proteins. DCC staining not in
association with the X chromosomes remains after detergent extraction
in htz-1 RNAi animals. (B) DPY-27 (green) localization to prophase
chromosomes (DAPI, blue) in vector and htz-1 RNAi treated embryonic
nuclei (.50 cell stage). DPY-27 staining to more than two chromo-
somes is observed in 32% of htz-1(RNAi) prophase nuclei (n=63) but
only observed in 11% of vector prophase nuclei (n=57). Mitotic nuclei
were identified using an antibody that recognizes H3S10Ph (red).
doi:10.1371/journal.pgen.1000699.g006
Figure 7. HTZ-1 is underrepresented on the silent X chromo-
somes of male and hermaphrodite germ lines. (A) Hermaphrodite
germ nucleus in pachytene of prophase I of meiosis stained with
antibodies specific to H3K27me3 (a mark enriched on the X, green),
HTZ-1 (red), and DAPI (grayscale). (B) Hermaphrodite germ nucleus in
diplotene of prophase I co-stained for MES-4 (enriched on autosomes,
green), HTZ-1 (red), and DAPI (grayscale). (C) Male germ nucleus in
pachytene of prophase I co-stained for H4K16ac (enriched on
autosomes, green), HTZ-1 (red) and DAPI (grayscale). In all cases, HTZ-
1 levels are lower on the X chromosome (arrows) than on autosomes.
doi:10.1371/journal.pgen.1000699.g007
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DCC binding and are characterized by the presence and
clustering of short sequence motifs called MEX motifs
[46,47,99]. MEX motifs are slightly enriched on the X
chromosome, but are also present on autosomes [46]. In principle,
HTZ-1 can affect either DCC targeting to rex sites, or dispersal to
dox sites, or both.
It should be pointed out that this model is different from the
interpretation of the HTZ-1 localization data presented in [67].
Using high-resolution analysis of HTZ-1 binding, the authors
showed that a subset of DCC peaks on the X chromosome
coincide with HTZ-1 peaks. One way to reconcile their data and
ours is to point out that the DCC/HTZ-1 overlap tends to be at
promoters (DCC dox sites), and less so at the highest peaks of
DCC binding (DCC foci or rex sites) [67]. Therefore, if HTZ-1 is a
negative regulator of DCC binding, it is more likely that HTZ-1
affects the targeting step to rex sites, but not the dispersal step to dox
sites. Another way to reconcile the data in the two studies is to
suggest that HTZ-1 at dox sites is modified posttranslationally (see
below) in such a way that permits DCC binding. According to this
model, MEX motifs attract DCC to the X chromosome, whereas
HTZ-1 negatively regulates DCC recruitment to rex sites. If a
MEX motif-containing sequence is not bound by HTZ-1 the DCC
will be recruited. However, if a MEX motif-containing sequence is
bound by HTZ-1, the DCC will be prevented from binding. From
sites of entry, the DCC then may be dispersed to dox sites in a
sequence and HTZ-1 independent manner. When HTZ-1 levels
are reduced by RNAi or mutation, the DCC will be able to bind
all MEX motif containing sites, whether they are on the autosomes
or on the X chromosome. Ectopic DCC binding to autosomes will
reduce the amount of DCC binding to the X chromosomes, and
dosage compensation will be impaired as a result. To test this
model, it will be important to observe DCC binding patterns
genome-wide at high resolution upon htz-1 depletion and to
determine whether ectopic DCC binding sites contain a DNA
sequence motif similar to MEX motifs.
An alternative possibility is that changes in the higher order
chromatin organization imposed by HTZ-1 determine whether
the DCC is able to bind the chromosome. H2A.Z has been
reported to alter the nucleosome surface, affect recruitment of
other chromatin components, and thereby modulate higher order
features of the chromatin fiber [77]. High levels of HTZ-1 on the
autosomes may result in alterations in the overall structure of the
chromatin fiber, which preclude DCC binding. Low levels of
HTZ-1 on the X chromosome would allow DCC binding. Upon
reduction of HTZ-1 levels, general disruption of higher order
chromatin folding would allow the DCC to bind both the X and
the autosomes. According to this model, the changes in chromatin
fiber folding are a direct consequence of HTZ-1 levels on the
chromosome. However, the model does not require complete
mutually exclusive binding of the DCC and HTZ-1 at high
resolution, and therefore does not conflict with the data in [67].
Finally, HTZ-1 may regulate expression of a DCC component,
or another gene needed for proper DCC localization. While HTZ-
1 is an obvious candidate for the DCC-repelling activity, it should
be noted that in principle another HTZ-1-regulated protein could
also perform this function. Our evidence, as yet, does not support
this model, as we do not observe a change in DCC protein levels
or sdc-2 RNA levels when htz-1 expression is reduced. In addition,
most DCC proteins are loaded into oocytes, and this maternal
load of DCC proteins is sufficient for healthy development.
Therefore, it is unlikely that the observed dosage compensation
defects in m+z2 htz-1 mutant animals are due to defects in
transcription of DCC genes. However, it remains possible that
HTZ-1 plays more subtle roles in regulating the exact levels and
timing of expression of dosage compensation genes. Nonetheless,
the difference in HTZ-1 levels in male and hermaphrodite X
chromosomes (Figure 2C) argue for a more direct role for HTZ-1
in the hermaphrodite specific-process of dosage compensation.
High-resolution analysis of HTZ-1 binding to the male X
chromosome may help distinguish between the models presented
above.
HTZ-1 depletion on the X chromosome
A question that remains unanswered is how HTZ-1 is
specifically targeted to autosomes, or conversely, how the X
chromosomes become depleted of HTZ-1. The small number of
developmentally important genes on the X chromosome relative
to autosomes can certainly contribute to this difference [67].
However, this model does not explain why the male X in adult
animals does not appear to be depleted of HTZ-1 at the
chromosomal level (Figure 2C). The X chromosome in the both
the male and hermaphrodite germ lines is subject to silencing
[50–52], and it is possible that the chromosome maintains some
memory of this silencing after fertilization. Such effects have been
seen on the sperm-derived X chromosome [100]. The differences
between the sperm derived X (which only hermaphrodite embryos
receive) and the oocyte-derived X (which both males and
hermaphrodites receive) may contribute to the sex-specific
differences in observed X-linked HTZ-1 levels. Comparison of
HTZ-1 dynamics in male and hermaphrodite embryos in early
development will be an important future area of investigation.
Different HTZ-1 pools for different functions
It is important to keep in mind that dosage compensation is a
chromosome-wide gene regulation mechanism that is super-
imposed on the unique transcriptional programs of individual X-
linked genes. While HTZ-1 levels on the dosage compensated X
chromosomes are reduced overall, the protein is not completely
absent. Indeed, HTZ-1 binds to the promoter of an X-linked
Figure 8. Model for HTZ-1 function in dosage compensation.
DNA sequence motifs, which are enriched on the X chromosome (X),
attract the DCC. HTZ-1, or a factor/activity dependent on HTZ-1, is
enriched on autosomes (A) and repels the DCC. As a consequence of
these two forces, in wild type cells the DCC is greatly enriched on the X
chromosomes. However, when HTZ-1 levels are low, the DCC is now
able to bind both the X chromosomes and the autosomes. Ectopic DCC
binding on autosomes titrates the complex away from the X
chromosomes and impairs dosage compensation.
doi:10.1371/journal.pgen.1000699.g008
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temporal activation [73]. It is possible that a pool of HTZ-1
functions at promoters, including promoters on the X chromo-
some, to promote timely regulation of gene expression. Superim-
posed on that is the global repression of the X chromosome by the
DCC. Thus, HTZ-1 may perform a double role: it regulates genes
both individually (by binding to promoters) and chromosome-wide
(by regulating DCC binding).
Different pools of HTZ-1 may differ in their histone partners
and/or the level of posttranslational modifications. Unlike yeast
(where the only histone H3 is most similar to H3.3), worms possess
both H3 and H3.3 [90]. Therefore, in principle, one population of
HTZ-1 in worms is able to form labile nucleosomes, while another
population can form stable nucleosomes. Furthermore, both
populations can be modified by various posttranslational modifi-
cations, increasing the number of potentially different ways in
which HTZ-1 can affect genome activity. Consistent with this
idea, acetylation of the N-terminal tail of Htz1 is necessary for the
anti-silencing property of Htz1 in S. cerevisiae, as unacetylatable
Htz1 shows no change in localization to anti-silenced genes, but
Sir complex spreading and decreased expression of anti-silenced
genes is observed [101]. Htz1 is also subject to C-terminal
SUMOylation. SUMO-Htz1 is implicated in directing chromo-
somes with persistent double-strand breaks to re-localize to the
nuclear periphery in budding yeast [102]. Posttranslational
modification of H2A.Z has also been observed in mammalian
dosage compensation [25]. H2A.Z is under-represented on the
inactive X in female mouse nuclei, but the small population of
remaining H2A.Z is specifically mono-ubiquitylated by the
Ring1b E3 ligase as part of the Polycomb repressor complex 1
(PRC1). Ring1b is also responsible for mono-ubiquitylation of
histone H2A in X inactivation [24]. Although it is not currently
understood how mono-ubiquitylation of H2A and H2A.Z function
in X inactivation, the fact that this modification is largely specific
to the inactive X suggests an important role. It is highly likely that
C. elegans HTZ-1 is subject to posttranslational modification and it
will be important to address how these modifications affect its role
both in dosage compensation and in other processes.
Barriers to repressor complex binding
The proposed role of HTZ-1 in dosage compensation is similar
to that of two proteins shown to function in germ line X-
chromosome silencing in C. elegans. The gene encoding MES-4 was
originally identified in a forward genetic screen with several other
genes whose mutations led to the same mes phenotype (maternal
effect sterility) [51]. MES-2, MES-3 and MES-6, are the protein
products of the other genes identified, and these form a Polycomb
repressor-like complex that is responsible for enriching the X
chromosomes with the silencing H3K27me3 mark [53]. Surpris-
ingly, MES-4, a histone H3 lysine 36 methyltransferase (HMT),
localizes to autosomes, not the X, and yet it has been shown to be
important for germ line X-chromosome silencing [51,57]. MRG-
1, an ortholog of the mammalian mortality factor related protein
MRG15, is the second autosome-enriched protein that has been
shown to play a role in germ line X chromosome silencing [103].
In both mes-4 and mrg-1 mutants, de-silencing of X-linked genes is
observed. It has been proposed that the activities of MES-4 and
MRG-1 on autosomes prevent the binding of a repressor protein
or complex and help limit repressor binding to the X
chromosomes. The proposed mode of action of MRG-1 and
MES-4 in germ line X chromosome silencing is similar to the
model of HTZ-1 function in dosage compensation we have
proposed.
Our model describing HTZ-1 as an autosomal DCC barrier is
also similar to the role of Htz1 in yeast in blocking the spread of
silencing complexes into euchromatic regions adjacent to telo-
meres [74]. In htz1D cells, the Sir proteins spread into these
regions, leading to silencing of genes. Recent evidence has shown
that loss of Htz1 leads to ectopic Sir complex localization that is
not limited to immediate anti-silenced regions, but, rather, is found
throughout the genome [75]. Thus, Htz1p in yeast may serve a
global, not just a local, anti-silencing function, similar to our
proposed model of HTZ-1 action in worms. Furthermore, in
Arabidopsis, H2A.Z also plays a global antisilencing role by
protecting DNA from methylation [69]. When H2A.Z incorpo-
ration is compromised, DNA methylation expands into regions
once protected by H2A.Z-containing nucleosomes. Therefore, a
function for H2A.Z in the protection against transcriptional
repression may be a widely conserved role for this histone variant.
Htz1 functions in parallel with other nucleosomal elements to
prevent heterochromatic spreading. The Set1 complex is respon-
sible for histone H3 lysine 4 methylation (H3K4me) and also has
an anti-silencing function [104]. A recent study found that Set1
and Htz1 cooperate to mediate global antisilencing in yeast [75].
This raises the possibility that there are other nucleosomal
modifications or elements that might function in X-chromosome
DCC restriction in parallel with HTZ-1 in C. elegans.
Materials and Methods
Strains and alleles
All strains used were maintained as described [105]. Strains
include: N2 Bristol strain (wild type), TY2384 sex-1(y263) X;
TY4403 him-8(e1489) IV; xol-1(y9) sex-1(y263) X; EKM11 htz-1
(tm2469) IV/nT1(qIs51) IV,V; MT12963 ssl-1(n4077)III/eT1
(III;V); SM1353 cha-1(p1182) IV; pxEx214(HTZ-1promoter::-
YFP::HTZ-1 + HTZ-1promoter::CFP::LacI +pRF4) [73].
RNA interference
E. coli HT115 bacteria expressing double stranded RNA for htz-
1, dpy-27, capg-1, his-71 (coding region), his-24, hil-3, hil-4, hil-5, hil-
6, hil-7, isw-1 or vector (polylinker), were used for feeding RNAi
using the Ahringer feeding RNAi clones [106]. To generate RNAi
vectors for let-418 and the 39 UTR of his-71 and his-72, the regions
were PCR amplified, digested with Bam HI and Bgl II (let-418)o r
Bgl II and Not I (his-71 and his-72), and cloned into the DT7










RNAi in N2 was initiated at the L1–L2 stage. Adults were then
transferred to new RNAi plates to produce progeny for 24 hours.
For IF/FISH, western, and RT-PCR analysis, RNAi progeny
were processed 24 hours post-L4. To score embryonic lethality in
the sex-1 strain, adult animals were allowed to lay eggs for
24 hours and the number of embryos laid was counted. The next
day the number of dead embryos and larvae were counted and the
percentage of embryonic lethality was calculated by dividing
number of dead embryos by the total number of embryos laid. To
score male rescue in him-8(e1489) IV; xol-1(y9) sex-1(y263) X, adult
animals were allowed to lay eggs for 24 hours. When adult animals
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was counted. Three days later the number of male progeny on
each plate was counted. Male viability was calculated by dividing
the number of male progeny observed by the expected number of
males. The him-8(e1489) mutation reproducibly results in 38%
male self-progeny [89], so the expected number of males was
determined to be 38% of total embryos laid. Male rescue=Num-
ber of males/(total embryos60.38). All RNAi was conducted at
20uC.
Immunostaining
Rabbit and rat a-HTZ-1 antibodies were raised against the C-
terminal 19 amino acids (NKKGAPVPGKPGAPGQGPQ) and
affinity purified. Polyclonal rat a-HTZ-1 was used at a dilution of
1:500, polyclonal rabbit a-HTZ-1 at a dilution of 1:100 for
immunofluorescence. Other primary antibodies used are: poly-
clonal rabbit a-DPY-27 at a dilution of 1:100 [38], polyclonal
rabbit a-MES-4 (Susan Strome [UC Santa Cruz], [57]) at 1:100,
rabbit antiserum a-acetyl-histone H4 (Lys16) (Upstate) at 1:100,
rabbit polyclonal a-trimethyl-histone H3 (Lys27) (Upstate) at
1:500, and mouse monoclonal a-phospho-histone H3S10 (6G3)
(Cell Signaling Technology) at 1:500. Secondary antibodies used
are: Fluorescein (FITC) conjugated donkey a-rabbit (Jackson
ImmunoResearch) and Cy3 conjugated donkey a-rabbit IgG
(Jackson ImmunoResearch) both at a dilution of 1:100. Embryos
were stained as described [34]. Adult animals were dissected and
stained as described [44]. In adults, somatic non-intestinal nuclei
near the cut site (vulval area) were observed. Images were captured
with a Hamamatsu ORCA-ERGA CCD camera mounted on an
Olympus BX61 motorized X-drive microscope using a 606 oil
immersion objective. Captured images were deconvolved using 3i
Slidebook imaging software. Projected images were taken at
0.2 mm intervals through samples. Adobe Photoshop was used for
assembling images.
Fluorescent in situ hybridization
FISH probe templates were generated by degenerate oligonu-
cleotide primed PCR to amplify purified yeast artificial chromo-
some DNA. The labeled X-paint probe was prepared and used as
described [44]. Hybridization was performed on adult animals
(24 hours post-L4) with or without previous RNAi treatment. For
X-paint hybridization followed by DPY-27 immunostaining,
sample and probe were denatured at 95uC for 3 minutes. For
X-paint hybridization followed by HTZ-1 immunostaining,
sample and probe were denatured at 78–80uC for 8–10 minutes
in a Hybaid OmniSlide in situ Thermal Cycler System (Thermo
Scientific). Imaging was conducted as described above.
Quantification of colocalization
3i Slidebook imaging software was used to measure colocaliza-
tion of DPY-27 (FITC) and X-Paint (Cy3) signals on images
obtained as described above. A FITC mask was set for each
nucleus z-stack and the correlation between signals was calculated
within this mask by the software. The FITC:Cy3 correlation
coefficient was recorded and used as an indication of colocaliza-
tion between DPY-27 and X-Paint.
Detergent extraction
Detergent extraction of nucleoplasmic protein from dissected
nuclei was performed by dissecting animals in 16sperm salts plus
1% Triton detergent [97]. Dissected animals were then processed
for either Fluorescent in situ hybridization or immunofluorescence.
Western blot analysis
For each treatment described, 100 animals (all 24 hours post-
L4) were picked into 1XM9, washed, and incubated for ten
minutes at 95uCi n1 9ml SDS-PAGE loading dye (0.1 M Tris-
HCl pH 6.8, 75 M Urea, 2% SDS, Bromophenol Blue for color)
plus 1 ml b-mercaptoethanol. The treated samples were then
loaded into either 6% acrylamide (for detection of DPY-27, MIX-
1, DPY-26, DPY-28, and CAPG-1) or 15% acrylamide gels (for
detection of HTZ-1). SDS-PAGE was performed and protein was
transferred onto nitrocellulose. The following antibodies and
dilutions were used: rabbit a-HTZ-1 at 1:500, rabbit a-DPY-27 at
1:500, rabbit a-CAPG-1 at 1:500 [38], rabbit a-DPY-28 (gift of K.
Hagstrom) at 1:500, rabbit a-DPY-26 (gift of K. Hagstrom) at
1:5000, rabbit a-MIX-1 (gift of R. Chan) at 1:500, mouse
monoclonal a- a-Tubulin (Sigma) at 1:1000, LI-COR IRDye
800CW Conjugated Goat (polyclonal) a-Mouse IgG at 1:10000,
LI-COR IRDye 800CW Conjugated Goat (polyclonal) a-Rabbit
IgG at 1:10000. Blots were scanned and band intensities were
quantified using an Odyssey Infrared Imaging System (LI-COR
Biosciences). Protein levels for DCC proteins and HTZ-1 were
normalized to a-tubulin. Relative protein levels after htz-1 RNAi
were calculated by dividing the normalized htz-1 RNAi level by
normalized vector RNAi level.
RT–PCR
Trizol (Invitrogen) was used to extract RNA from all samples.
Worms were washed from RNAi plates or normal OP50 plates
24 hours post L4, washed with M9 and stored at 280uC until
extraction. For RNA extraction, samples were thawed on ice and
tissue was homogenized by grinding using a microcentrifuge tube
pestle. Tissue was ground in three 60-second intervals and re-
frozen in liquid nitrogen between each interval. During the final
60-second interval, 250 ml of Trizol was added to the tube, and
when completed, another 250 ml was added for a total volume of
500 ml Trizol and the standard protocol was used to extract RNA
from the homogenized samples (Invitrogen). DNA-Free kit
(Applied Biosystems) was used to digest remaining DNA
contamination.
Reverse transcription (RT) reactions were performed utilizing
the High Capacity cDNA Reverse Transcription Kit with RNase
Inhibitor (Applied Biosystems). 1 ml of DNase-treated RNA was
used in each RT reaction.
PCR was used to observe relative levels of htz-1, R08C7.10, and
act-1 (actin) expression levels. The following primers were used
with a 60uC annealing temperature:
act-1: gctatgttccagccatccttc and aagagcggtgatttccttctg
htz-1: tggctggaggaaaaggaaag and aacgatggatgtgtgggatg
R08C7.10: gtagaccaaaccagccagca and agcgccttgacgatacttttt
Real-time PCR analysis
Real-time PCR analysis was conducted as described [98]. The
following primers were used with an annealing temperature of
59uC:
act-1: same as above
htz-1: gcgctgccatcctcgaat and gggctcccttcttgttcatc
sdc-2: ggaaacaagaccgacaggaa and gatgcaatagtacacgccaaatc
Relative htz-1 and sdc-1 expression levels were calculated using
the Pfaffl method [107] incorporating the PCR efficiency for each
primer set as determined by a 10-fold dilution series for each
primer set in each reaction. Reactions were conducted in triplicate
per experiment. Data shown are resulting averages from three
experiments.
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Figure S1 a-HTZ-1 antibody is specific. (A) HTZ-1 (red), DPY-
27 (green), and DAPI (grayscale) staining of adult intestinal nuclei
in vector and htz-1 RNAi treated hermaphrodites. The HTZ-1
signal is greatly reduced after htz-1 RNAi. (B) a-HTZ-1 Western
blot. a-HTZ-1 recognizes a band of the expected size (,15 kDa)
in both embryonic extract and adult protein samples. The a-HTZ-
1 signal is reduced in htz-1 RNAi treated animals as compared to
vector treated animals.
Found at: doi:10.1371/journal.pgen.1000699.s001 (7.19 MB TIF)
Figure S2 Transgenic YFP-HTZ-1 is also under-represented on
the dosage compensated X chromosomes. Embryos after the onset
of dosage compensation were stained with a-GFP antibodies to
observe YFP-HTZ-1 localization (red), a-DPY-27 to mark the X
chromosome (green) and DAPI (grayscale). Arrows in the top
panels indicate enlarged nucleus shown below. YFP-HTZ-1 levels
are reduced in the territory of the dosage compensated X
chromosomes.
Found at: doi:10.1371/journal.pgen.1000699.s002 (7.78 MB TIF)
Figure S3 tm2469 deletion affects htz-1 and R08C7.10 expres-
sion. (A) Reverse-transcription polymerase chain reaction (RT-
PCR) analysis of expression of htz-1, R08C7.10 and actin (control)
in wild type (+/+), heterozygous (htz-1(tm2469)/nT1), or homozy-
gous (htz-1(tm2469)) animals. Expression of both htz-1 and
R08C7.10 is affected in homozygous animals. Contaminating
amplification product from residual DNA in the RNA sample is
indicated by a star. (B) Schematic showing relative positions of htz-
1 and R08C7.10 on chromosome IV (not to scale). The tm2469
deletion removes most of the coding region of htz-1. In addition, it
likely the affects the promoter or other cis control elements of the
R08C7.10, a gene located only 522 base pairs away from the
deletion.
Found at: doi:10.1371/journal.pgen.1000699.s003 (5.72 MB TIF)
Figure S4 htz-1-depleted embryos also show compromised DCC
localization. Vector and htz-1 RNAi embryos were stained with a-
Phospho-H3 Ser10 (red) (to mark mitotic nuclei) and a-DPY-27
(green). After htz-1 RNAi, 16% of embryos with Phospho-H3
Ser10 staining (.50 cell stage) had diffuse nuclear DPY-27
localization (n=372), as opposed to 2% in vector embryos
(n=314).
Found at: doi:10.1371/journal.pgen.1000699.s004 (2.89 MB TIF)
Table S1 RNAi of the following genes did not result in
significant (.10%) male rescue.
Found at: doi:10.1371/journal.pgen.1000699.s005 (0.12 MB
DOC)
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